WBD — Warner Bros. Discovery, Inc.

As of 2026-09-13 the stock sits at $28.04, near the top of its $17.08-$30 52-week range, up 3.93% over three months and 3.32% over six months - but that strength is merger-arbitrage plumbing, not enthusiasm for the business. The $28.04 price against a $31.00 all-cash bid implies the market assigns a very high probability to the Paramount Skydance deal closing roughly on the current timeline. Offsetting that confidence: an active Clayton Act antitrust suit from 12 state Attorneys General plus the WGA, Paramount's September 2026 demand for a $1.88B bond from plaintiffs to cover 'ticking fees' and delay costs, a trial schedule extending toward mid-2027, and consistent insider selling with zero open-market insider purchases over the past year. Sell-side is split (12 buy, 19 hold, 1 sell), with the only aggregated target at $31.00 - i.e., analysts are mostly re-stating the deal price, not underwriting the business.

The top line is in a steady structural decline, not a blip. Quarterly revenue fell from $9.98B in Q3 2023 and $10.28B in Q4 2023 to $8.72B in Q2 2026; fiscal 2024 revenue was $39.3B, fiscal 2025 came in at $37.3B (-5.2%), and the FY2026 consensus of $36.2B implies another ~3% decline. The Q2 2026 print of $8.72B was down 11.2% year over year versus Q2 2025's $9.81B. Margins are the one genuinely improving line: GAAP operating margin went from -1.8% (Q4 2023), -2.7% (Q1 2024) and -1.9% (Q2 2025) to +6.8% (Q3 2025), +5.7% (Q4 2025) and +6.2% (Q1 2026), before slipping to +2.7% in Q2 2026 on Studio volatility. Reported net income is largely noise: -$9.99B in Q2 2024 (goodwill impairment), +$1.58B in Q2 2025 (one-off gains), -$2.92B in Q1 2026 (impairment), +$149M in Q2 2026. The cleanest read is cash: free cash flow fell from $4.43B in FY2024 to $3.09B in FY2025 to $2.18B on a TTM basis, with the $476M FCF outflow in Q1 2026 a reminder of how lumpy content spend makes this business. Debt reduction is real and consistent: long-term debt dropped from $43.5B in Q3 2023 to $30.5B in Q2 2026, about $13B of paydown.

Traditional multiples are close to useless here. TTM EPS is -$1.26, giving a P/E of -22.08; next-FY consensus EPS is -$1.146, so there is no forward P/E either. PEG of 0.164 is arithmetic noise on a negative earnings base. On sales, WBD trades at 1.95x TTM revenue against a five-year average P/S of just 0.95x - roughly double its own history, which is entirely a function of the $31 cash bid pulling the shares up, not any re-rating of standalone earnings power. The reported EV/EBITDA of 16.7x is distorted by impairment charges depressing the denominator (implied TTM EBITDA of only ~$5.9B); on a normalized adjusted-EBITDA basis of roughly $8B, the current ~$99B enterprise value is closer to 12x - expensive for a business with a shrinking linear core. Against that, price-to-book of 2.14x looks less alarming given $32.8B of book equity, and the current ratio of 0.777 is genuinely weak.

There is no earnings playbook that works right now. With negative trailing and forecast EPS, price is decoupled from any profit-based anchor and is instead pinned to a contractual $31.00 cash price. Every wiggle in the share price between now and a court ruling is a change in the market's implied probability and timing of that deal, not a change in the earnings outlook. The practical implication: if the merger breaks, there is no earnings floor anywhere near $28 - the market was valuing the standalone business in the high-teens a year ago (52-week low of $17.08), and my own standalone math puts fair value closer to $15-16. Anyone owning WBD at $28.04 today is underwriting a legal outcome, not a P/E rerating, and should size the position accordingly.

As of 2026-09-13, the technical setup was neutral and range-bound rather than trending. RSI(14) stood at 51.98 - dead center, neither overbought nor oversold. The price was 1.24% below its 20-day SMA but 3.10% above its 50-day and 2.37% above its 200-day, consistent with a slow grind higher off a base rather than a breakout. Trailing returns were modest and compressing: -0.74% over one week, +1.41% over one month, +3.93% over three months and +3.32% over six months. The stock is effectively coiled between roughly $27 and the hard $31 offer ceiling, so there is no meaningful technical edge to exploit - support and resistance levels carry far less information than the next court filing. Entry timing here is a function of legal headlines, not moving averages.

• Antitrust and regulatory scrutiny of media consolidation is the dominant macro variable: federal and ~70 international clearances are already secured, but a 12-state AG coalition and the WGA are litigating under the Clayton Act, with a merits trial stretching toward mid-2027 and Paramount seeking a $1.88B bond from plaintiffs to cover delay costs.
• Interest rates and a heavy debt load: ~$28.6B of net debt and roughly 3.4x net leverage mean WBD's equity is highly sensitive to refinancing costs and any backup in yields, even though rate stabilization over the past year has helped.
• Structural cord-cutting and linear advertising decline: the Global Linear Networks segment (CNN, TNT, HGTV) is the profit engine and the shrinking part of the business, so affiliate-fee resets and ad cyclicality hit the highest-margin revenue first.
• Competitive and content-cost pressure across streaming and theatrical: HBO Max passed 140M global subscribers, but competing against Netflix, Amazon and Disney for content spend while theatrical box office remains volatile keeps Studio results lumpy.
• Labor and talent dynamics: the WGA's direct participation in the merger litigation is unusual and adds a Hollywood-labor dimension to what would normally be a pure antitrust question, with knock-on risk to production schedules and content output.

• Antitrust court milestones: rulings on temporary restraining orders and/or a preliminary injunction, the pending $1.88B bond demand from Paramount filed in September 2026, and the merits trial schedule extending toward mid-2027 - any of these can move the arbitrage spread sharply.
• Q3 2026 earnings, tentatively scheduled for November 5, 2026: the key reads will be linear TV erosion rates, DTC profitability milestones past the 140M subscriber mark, and any updated legal disclosure on the Paramount closing timeline.
• Deal resolution itself - a close at $31.00 cash, a break with no replacement bid (which would re-price shares toward standalone value), or the emergence of a competing bidder or revised terms if the current deal is blocked.
• Continued deleveraging and possible non-core asset sales, which would raise standalone break-up value even if the merger fails.

• Deal break risk is the single largest risk: on my standalone math (roughly 8.5x normalized ~$8B adjusted EBITDA less ~$28.6B net debt, about $15.50 per share), a failed merger implies 40%+ downside from $28.04.
• Multi-year litigation delay: a trial running through mid-2027 plus ticking fees means the present value of the $31 cash offer erodes the longer shareholders wait, and the $1.88B bond request signals the parties themselves expect meaningful slippage.
• Structural decline in linear networks may not be offset by streaming: revenue has fallen five consecutive fiscal years on a run-rate basis and free cash flow has dropped 46% year over year to $2.18B, while the current ratio of 0.777 leaves limited near-term balance-sheet cushion.
• Earnings quality and comparability risk: each of the last eight quarters contains a large one-off charge or gain (a $9.99B impairment loss in Q2 2024, a $2.92B net loss tied to impairment in Q1 2026, a $1.58B one-off gain in Q2 2025), making any reported EPS or P/E figure unreliable and masking the underlying trajectory.
• Governance and alignment signals: persistent insider selling, including a notable September 2026 executive share sale, with zero reported open-market insider purchases over the past year.
• Low analyst coverage depth on the standalone case: the consensus target of $31.00 comes from a single aggregated analyst and largely restates the deal price, so there is little independent underwriting of break-scenario value.

At $28.04 on 2026-09-13, this is not a fundamental investment - it is a merger-arbitrage position with a 9.5% spread to a $31.00 cash offer that will not be tested in court until roughly mid-2027. The standalone business is genuinely weak: revenue down 6.1% TTM, free cash flow down 46% to $2.18B, ROIC of 0.7%, current ratio of 0.777, and no clean earnings anchor with forward EPS estimated at -$1.146. My probability-weighted fair value is about $25.40 (75% odds of a discounted $31 close, 25% odds of a break to ~$15.50 standalone), which sits below the current price - so the spread is not compensating for the break scenario. I would not be a buyer here and would treat any existing position as a short-dated, size-limited legal bet rather than a long-term holding.

Probability-weighted expected value rather than a single-scenario multiple: 75% weight on the $31.00 all-cash Paramount Skydance offer discounted roughly 12 months at 8% (~$28.70), plus 25% weight on a break-up standalone value of ~$15.50 (8.5x normalized ~$8B adjusted EBITDA = ~$68B EV, less ~$28.6B net debt on ~2.51B shares, cross-checked at ~1.0x P/S versus the 0.95x five-year average). The result, 0.75 x $28.70 + 0.25 x $15.50, equals approximately $25.40 - below the $28.04 price as of 2026-09-13.